Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzoic acid add-on study in treatment-resistant schizophrenia
ACTRN12615000460505Phase 2Terminated
- Sponsor
- University of Otago
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Benzoic acid in schizophrenia, sponsored by University of Otago. Primary endpoints: Positive and Negative Symptom Scale, Scale for the Assessment of Negative Symptoms and 1 more. Started Mar 2016; status: terminated.
02
Drugs
Benzoic acid
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ACTRN12615000460505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000460505.